Abstract
Novel pyrazolopyridine-4-yl pyridazinone derivatives serve as phosphodiesterase inhibitors and are useful compounds for use in pharmaceutical products. Specifically, the compounds of the present invention are pyrazolopyridine-4-yl pyridazinone derivatives represented by the following general formula (1): (Example: 6-(2-ethyl-7-methoxy-pyrazolo[1,5-a]pyridine-4-yl)-5-methyl-4, 5-dihydro-3(2H)-pyridazinone).
Original language | English |
---|---|
Patent number | US7763617(B2) |
IPC | A61K31/501; A61P11/06; A61P25/24; A61P29/00; A61P33/08; C07D401/14; C07D403/14 |
Publication status | Published - 27 Jul 2010 |